Abstract: BACKGROUND: Our aim was to evaluate the clinical impact of routine amniotic fluid and neonatal surface swab microbiology at Caesarean section. MATERIALS AND METHODS: Microbiology data from 1 537 neonates delivered by Caesarean section were analysed in the light of clinical outcome. RESULTS: 1 340 (87%) neonates had non-pathogenic bacteria or negative culture results from both amniotic fluid and surface swab samples. Of the 197 (13%) neonates with pathogenic bacteria, 22 (1.4%) were diagnosed with infection, but only in 6 (0.4%) were the bacteria presumed to be responsible for the infection. Amniotic fluid and surface swab culture had sensitivities of 54% and 35%, and positive predictive values of 14% and 17%, respectively, for detecting a neonate at risk of infection. CONCLUSION: Amniotic fluid and neonatal surface swab microbiology at Caesarean section contributes little if anything to postnatal management and can be safely dropped from operative routine. 
Bacteriology of amniotic fluid samples and neonatal skin surface swabs at caesarean section was proposed as a predictor of infection during the first days of life 1, 2 and has been routinely performed in some institutions. However, there is ongoing debate as to whether isolates from these sources influence the development of neonatal infection and subsequent clinical management. Some authors have attributed adverse perinatal outcome to the bacteria isolated from amniotic fluid [3] [4] [5] [6] [7] [8] [9] and have proposed sampling amniotic fluid as an infection screening programme in preterms 3, 4 . Others have contended that bacterial invasion of the amniotic cavity does not increase the risk of neonatal infection [10] [11] [12] [13] . There is even debate over the effects of Ureaplasma urealyticum on neonatal sepsis, meningitis and bronchopulmonary dysplasia [14] [15] [16] . Studies on this issue are rare. Most were conducted decades ago 1, 11 or limited to subgroups such as preterm neonates or mothers with premature rupture of the membranes 6, 7, 9 . More particularly, sample sizes were small 6, [11] [12] [13] .
Our aim was to evaluate the utility of routine amniotic fluid and neonatal surface swab microbiology at caesarean section and its impact on subsequent clinical management, regardless of gestational age or other limiting factors. A key purpose was to determine the sensitivity and positive predictive value of the microbiology findings for neonatal infection. 
Material and Methods
Patient population. In a retrospective study over 24 months (July 2003 -June 2005 we analysed the microbiology data of all 1719 neonates delivered via caesarean section at the Department of Obstetrics, University Hospital Zurich, Switzerland. We excluded 182 neonates on whom no amniotic fluid and skin surface microbiology had been performed.
Gestational age in the remaining 1537 neonates ranged from 24 to 43 weeks (median 38 weeks). Median birth weight was 2890g (range 260g to 5000g). Culture results were divided into two broad groups with respect to the clinical context: pathogenic (e.g., Enterobacteriaceae, U. urealyticum and β-haemolytic Streptococcus group B, in any amount) and non-pathogenic (e.g., lactobacilli, coagulase-negative staphylococci and viridans streptococci, also in any amount). Classification of low-virulent Our data show that routine bacteriology of amniotic fluid and the neonatal surface at caesarean section contributes little if anything to neonatal management. In our population, most of the neonates were delivered at term. However, for preterms or neonates with serious perinatal risk factors, amniotic fluid analysis might be useful to complement clinical examination and microbiological workup; its positive predictive value might improve in this setting. Skin swab analysis, on the other hand, has no value and should be discarded 4 .
Conclusion
Routine amniotic fluid and neonatal surface swab bacteriology at caesarean section contributes little if anything to clinical management. In view of its financial implications, such screening should not be performed routinely. 
